Editorial content

BioPharma Dealmakers June 2016 edition

Our biggest issue of the year is here. The June issue includes over 20 company profiles and 4 feature articles focused around the areas of academic partnering, infectious diseases, industry insight and inflammation.

Go to the profile of Raveena Bhambra
Jun 01, 2016
3
0
Upvote 3 Comment

Read the June 2016 edition of BioPharma Dealmakers....

Read about the companies looking for partnerships from our June edition -

Aeglea Biotherapeutics

Biotest AG

CINVESTAV

Curileum

D3 Medicine

DTU Biosustain-Novo Nordisk Foundation Center for Biosustainability

GSK Vaccines

Helperby

Institut Carnot Calym

Lantern Pharma

Motif Bio

NanoViricides

NIH-National Institute of Allergy and Infectious Diseases (NIAID)

NYU Langone Medical Center- Office of Therapeutics Alliances

Rock Creek

Sanofi Pasteur

Sensor Pharma

The Antibody Lab

The University of Manchester

Ulster University

University of Dundee

Valneva

Verseon

Read the in-depth partnering features from our June edition that compliment the therapeutic and technology areas of the companies above -

Partnerships key to combating viral epidemics

What is the value of a deal?

Dealmaking for inflammatory disorders


Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Publishing Group

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 12 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.